申请人:ALMIRALL SA
公开号:WO2011035900A1
公开(公告)日:2011-03-31
The present invention relates to thiadiazole derivatives of formula (I), to processes for their preparation and to pharmaceutical compositions containing them. These compounds are potent agonists of S1P1 receptors and thus, they are useful In the treatment, prevention or suppression of diseases and disorders known to be susceptible to improvement by sphingosine-1-phosphate receptors agonists (S1P1), such as autoimmune diseases, chronic immune and inflammatory diseases, transplant rejection, malignant neoplastic diseases, angiogenic-related disorders, pain, neurological diseases, viral and infectious diseases.
本发明涉及式(I)的噻二唑衍生物,其制备过程以及包含它们的药物组合物。这些化合物是S1P1受体的强激动剂,因此它们可用于治疗、预防或抑制那些已知可通过激动鞘氨醇-1-磷酸受体(S1P1)得到改善的疾病和失调,例如自身免疫性疾病、慢性免疫和炎症性疾病、移植排斥反应、恶性肿瘤、与血管生成相关的失调、疼痛、神经疾病、病毒性和传染性疾病。